BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4043221)

  • 1. Central opioid-like influence of a tetrapeptide from hamster embryo (kentsin) on gastrointestinal motility in dogs.
    Bueno L; Fioramonti J; Menezo Y
    Eur J Pharmacol; 1985 Aug; 114(1):67-70. PubMed ID: 4043221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tetrapeptide isolated from hamster embryo with central opiate properties on gastrointestinal motility but not on pain perception.
    Buéno L; Fargeas MJ; Fioramonti J; Menezo Y
    Life Sci; 1986 Jul; 39(2):141-6. PubMed ID: 3014251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of corticotropin-releasing factor on plasma motilin and somatostatin levels and gastrointestinal motility in dogs.
    Bueno L; Fargeas MJ; Gue M; Peeters TL; Bormans V; Fioramonti J
    Gastroenterology; 1986 Oct; 91(4):884-9. PubMed ID: 2875010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kentsin: tetrapeptide from hamster embryos produces naloxone-sensitive effects without binding to opioid receptors.
    Fox DA; Ayres EA; Wire WS; Lui G; Yamamura HI; Burks TF
    Peptides; 1987; 8(4):613-8. PubMed ID: 2819832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of opiate receptors in the effects of trimebutine on intestinal motility in the conscious dog.
    Fioramonti J; Fargeas MJ; Bueno L
    J Pharm Pharmacol; 1984 Sep; 36(9):618-21. PubMed ID: 6149288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of morphine and cyclazocine on gastrointestinal motility in conscious dogs.
    Fioramonti J; Fargeas MJ; Buéno L
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):141-50. PubMed ID: 6497499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral antagonistic action of trimebutine and kappa opioid substances on acoustic stress-induced gastric motor inhibition in dogs.
    Gué M; Pascaud X; Hondé C; Junien JL; Buéno L
    Eur J Pharmacol; 1988 Jan; 146(1):57-63. PubMed ID: 2895010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different targets for i.v. vs. i.c.v. administered morphine for its effect on colonic motility in dogs.
    Fioramonti J; Fargeas MJ; Bueno L
    Eur J Pharmacol; 1985 Oct; 117(1):115-20. PubMed ID: 4085540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the effects of centrally-administered morphine on colonic motility in dogs by the benzodiazepine receptor antagonist RO 15-1788.
    Fioramonti J; Fargeas MJ; Buéno L
    Life Sci; 1987 Sep; 41(12):1449-55. PubMed ID: 3041141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin: a central neuromodulator of gastrointestinal motility in the dog.
    Bueno L; Fioramonti J; Fargeas MJ; Primi MP
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G15-9. PubMed ID: 3966557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central control of intestinal motility by prostaglandins: a mediator of the actions of several peptides in rats and dogs.
    Bueno L; Fargeas MJ; Fioramonti J; Primi MP
    Gastroenterology; 1985 Jun; 88(6):1888-94. PubMed ID: 3858191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dermorphin on gastrointestinal transit in rats.
    Broccardo M; Improta G; Nargi M; Melchiorri P
    Regul Pept; 1982 Jul; 4(2):91-6. PubMed ID: 7122927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral control of gastrointestinal and colonic motility by endogenous opiates in conscious dogs.
    Bueno L; Fioramonti J; Hondé C; Fargeas MJ; Primi MP
    Gastroenterology; 1985 Feb; 88(2):549-56. PubMed ID: 3965344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of growth hormone-releasing factor (GRF) on intestinal motility in dogs: involvement of dopaminergic receptors.
    Bueno L; Fioramonti J; Primi MP
    Peptides; 1985; 6(3):403-7. PubMed ID: 2999724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of gastrointestinal motility by loperamide in dogs.
    Fioramonti J; Fargeas MJ; Bueno L
    Dig Dis Sci; 1987 Jun; 32(6):641-6. PubMed ID: 3568951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fedotozine on gastrointestinal motility in dogs: mechanism of action and related pharmacokinetics.
    Pascaud X; Honde C; Le Gallou B; Chanoine F; Roman F; Bueno L; Junien JL
    J Pharm Pharmacol; 1990 Aug; 42(8):546-52. PubMed ID: 1981581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible central serotonergic mechanism involved in the effects of morphine on colonic motility in dog.
    Bueno L; Fioramonti J
    Eur J Pharmacol; 1982 Aug; 82(3-4):147-53. PubMed ID: 6982170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of trimebutine on intestinal motility in dogs].
    Hondé C; Le Gallou B; Pascaud X; Junien JL
    Presse Med; 1989 Feb; 18(6):294-7. PubMed ID: 2522226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuropeptide FF on intestinal motility and temperature changes induced by endotoxin and platelet-activating factor.
    Million M; Fioramonti J; Zajac JM; Buéno L
    Eur J Pharmacol; 1997 Sep; 334(1):67-73. PubMed ID: 9346330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral opioid receptors mediate gastrointestinal secretory and motor effects of dermorphin N-terminal tetrapeptide (NTT) in the dog.
    Soldani G; Del Tacca M; Bernardini MC; Bardon T; Ruckebusch Y
    Neuropeptides; 1987 Jul; 10(1):67-76. PubMed ID: 2823168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.